Maintaining Progress/Long-Term Strategies Building a Sustainable Lifestyle : While using medications to aid weight loss, it is crucial to also focus on creating a sustainable lifestyle and build mental toughness
The titration schedule is individualized based on clinical response, weight trajectory, and tolerability
Not medical advice.* How to Flatten the Spike Eating protein before carbohydrates significantly reduces postprandial glucose spikes, a strategy that complements GLP-1 medication: Eat protein first - Start with chicken, fish, or eggs before touching carbs Add fiber-rich vegetables - Broccoli, spinach, and asparagus slow glucose absorption Include healthy fats - Avocado or olive oil further blunts the glucose curve Add acidic components - Lemon juice or vinegar with meals lowers glycemic response This protein-first eating order is especially effective for GLP-1 users managing both weight and blood sugar
Just one day before the patent fell in India, Novo Nordisk received US FDA approval for a higher-dose version of Wegovy Wegovy HD, with its higher dose and superior clinical data, was FDA-approved the day before the patent fell, and 49 downstream patents protect its delivery systems through 2042
From diabetes control to weight management, one molecule is reshaping the market: Semaglutide What started as a breakthrough therapy is now turning into a full-blown brand war in India Multiple pharma giants are entering the space all racing to capture a share of the rapidly growing GLP-1 market
Ltd., personal fees from Eisai Inc., personal fees from Abbvie GK, personal fees from Sumitomo Dainippon Pharma Inc., personal fees from Ayumi Pharmaceutical Inc., personal fees from Medilead Inc., personal fees from Novo Nordisk Japan Inc., personal fees from Novartis Pharma Inc., personal fees from GSK Inc., outside the submitted work.Barnaby Hunt and Richard Pollock are employees of Ossian Health Economics and Communications, which received consulting fees from Novo Nordisk Pharma Ltd
.jpg)
